Concepedia

Anat Gershoni

AG

5

Publications

552

Citations

5

H-Index

2016

Active since

Affiliations

Weizmann Institute of Science(Current)

The University of Texas MD Anderson Cancer Center

Anat Gershoni is an author at Weizmann Institute of Science specializing in cancer research, medicine, and tumor biology.

ORCID

Top concepts

Publications per year

2016–2022

5

Publications

5

A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation

Eran Kotler, Odem Shani, Guy Goldfeld et al. · Molecular Cell · 2018 · 290 citations · Full text

, , +10

The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation

Yael Aylon, Anat Gershoni, Ron Rotkopf et al. · Genes & Development · 2016 · 107 citations · Full text

, , +15

Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients

Ori Hassin, Nishanth Belugali Nataraj, Michal Shreberk‐Shaked et al. · Nature Communications · 2022 · 97 citations · Full text

, , +18

LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state

Noa Furth, Ioannis S. Pateras, Ron Rotkopf et al. · Life Science Alliance · 2018 · 33 citations · Full text

, , +18

Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins

Saptaparna Mukherjee, Martino Maddalena, YiQing Lü et al. · Proceedings of the National Academy of Sciences · 2022 · 25 citations · Full text

, , +16

Rows per page

1–5 of 5